CANCER CENTER ADMINISTRATION The Kimmel Cancer Center (KCC) Administration serves to meet the operational and financial needs of the center, providing efficient and cost-effective management of the center, and helping to ensure that the research, clinical, and training goals of the Center are realized. Administration provides key support to the Center Director, the Associate Directors, Program Leaders, Directors and Oversight Committees of the Shared Resources, Clinical Leaders, the Executive Committee, the internal Basic Science and Clinical Advisory Committees, and the External Scientific Advisory Committee. KCC Administration participates in the planning and implementation of all activities throughout the programs and shared resources of the center, including the conduct of basic, clinical, and translational research, educational and training programs, and clinical trials activities. Overall responsibility for the effective operation of Administration lies with the Administrative Director, Richard L. Davidson, Ph.D., who has over 30 years experience in the establishment, operation, and management of large-scale research activities. Dr. Davidson also serves as Associate Director for Shared Resources, overseeing the activities of all the KCC shared resources. Dr. Davidson's dual responsibility over both Administration and Shared Resources provides not only for efficiency of management but also for seamless coordination of the two of them. Dr. Davidson reports directly to the Center Director. Administration serves as the link between the center and the university and hospital offices for administration, financial affairs, space management, maintenance, construction, human resources, intellectual property, information technology, and legal counsel. The major activities of Administration involve the following areas: 1) financial management of all CCSG accounts, including those of the shared resources;2) operational management of the shared resources;3} space management, maintenance, and renovation;4) pilot-project funding mechanisms;5) strategic planning activities;6) Center retreats, symposia, seminars, and meetings;7) clinical trials activities;8) Oncology Grand Rounds;9) multidisciplinary treatment centers for patients;10) faculty recruitment;11) human resources;12) educational and training programs;and 13) grant planning and preparation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA056036-13
Application #
8378881
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
13
Fiscal Year
2012
Total Cost
$250,717
Indirect Cost
$87,847
Name
Thomas Jefferson University
Department
Type
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Heeke, Arielle L; Pishvaian, Michael J; Lynce, Filipa et al. (2018) Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types. JCO Precis Oncol 2018:
Parent, Kristin N; Schrad, Jason R; Cingolani, Gino (2018) Breaking Symmetry in Viral Icosahedral Capsids as Seen through the Lenses of X-ray Crystallography and Cryo-Electron Microscopy. Viruses 10:
Rappaport, Jeffrey A; Waldman, Scott A (2018) The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia. Front Oncol 8:299
Pandya, Kalgi D; Palomo-Caturla, Isabel; Walker, Justin A et al. (2018) An Unmutated IgM Response to the Vi Polysaccharide of Salmonella Typhi Contributes to Protective Immunity in a Murine Model of Typhoid. J Immunol 200:4078-4084
Hussain, Maha; Daignault-Newton, Stephanie; Twardowski, Przemyslaw W et al. (2018) Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012. J Clin Oncol 36:991-999
Shafi, Ayesha A; Schiewer, Matthew J; de Leeuw, Renée et al. (2018) Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response. Eur Urol Oncol 1:325-337
Meyer, Sara E; Muench, David E; Rogers, Andrew M et al. (2018) miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential. J Exp Med 215:2115-2136
Mazina, Olga M; Mazin, Alexander V (2018) Reconstituting the 4-Strand DNA Strand Exchange. Methods Enzymol 600:285-305
Magee, Michael S; Abraham, Tara S; Baybutt, Trevor R et al. (2018) Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases. Cancer Immunol Res 6:509-516
Chervoneva, Inna; Freydin, Boris; Hyslop, Terry et al. (2018) Modeling qRT-PCR dynamics with application to cancer biomarker quantification. Stat Methods Med Res 27:2581-2595

Showing the most recent 10 out of 807 publications